State lawmakers in Maryland and Minnesota are planning to revamp and reintroduce legislation that would create rate-setting commissions for prescription drugs after bills in both states died last session. New Jersey lawmakers also have introduced bills that are still pending for the state’s 2018-2019 session. Brand drug manufacturers oppose rate-setting legislation, and fought to kill Maryland’s proposal. The rate-setting bills were based on model legislation published by the National Academy for State Health Policy. The NASHP model legislation provides an...